Organometallics
Article
nium tetrafluoroborates were dried in vacuo in a desiccator and stored
in a refrigerator. Diazonium tetraphenylborates were prepared
immediately before use according to the literature procedure.21
Caution! Diazonium tetraphenylborates in the crystalline state can
undergo explosive decomposition even with very slight mechanical
stimulation! Enaminone 1 was prepared according to the procedures
reported in ref 24.
23.1. Anal. Calcd for C27H27BBrN3O (500.24): C, 64.83; H, 5.44; N,
8.40. Found: C, 64.93; H, 5.47; N, 8.19.
4-(4-Ethoxycarbonylphenyldiazenyl)-3-methyl-1,1-diphenyl-
6,7,8,9-tetrahydro-5H-[1,3,2 λ4]oxazaborino[3,4-a]azepine (3f).
Yield: 50%. Mp: 158−160 °C. 1H NMR (400 MHz, CDCl3): δ
8.10−8.06 (m, 2H), 7.66−7.62 (m, 2H), 7.40−7.20 (m, 10H), 4.42−
4.34 (m, 2H), 3.69−3.57 (m, 2H), 3.30−3.26 (m, 2H), 2.60 (s, 2H),
1.80−1.70 (m, 4H), 1.43−1.30 (m, 5H). 13C NMR (101 MHz,
CDCl3): δ 180.5, 173.6, 166.4, 155.8, 133.2, 131.9, 130.9 130.6, 130.3,
127.4, 126.8, 121.5, 61.2, 51.4, 29.9, 29.7, 26.0, 23.4, 23.3, 14.5. Anal.
Calcd for C30H32BN3O3 (493.40): C, 73.03; H, 6.54; N, 8.52. Found:
C, 72.81; H, 6.59; N, 8.29.
General Procedures for the Preparation of Oxazaborines 3.
Method A. This methodology was adopted from ref 24.
Method B. To a cold (5 °C) mixture of β-enaminone 1 (5 mmol)
and sodium acetate (5 mmol) in dry dichloromethane (15 mL) was
added benzenediazonium tetrafluoroborate (5 mmol). The reaction
mixture was stirred at room temperature for 24 h. Sodium acetate was
removed by suction, and to the crude reaction mixture was added
BPh3 (10 mmol). The solution was stirred for 24 h at room
temperature. The solvent was evaporated in vacuo. The crude residue
was chromatographed on silica gel with dichloromethane as the mobile
phase to give the corresponding oxazaborines 3.
4-(4-Cyanophenyldiazenyl)-3-methyl-1,1-diphenyl-6,7,8,9-tetra-
hydro-5H-[1,3,2 λ4]oxazaborino[3,4-a]azepine (3g). Yield: 69%. Mp:
1
213−215 °C. H NMR (400 MHz, CDCl3): δ 7.72−7.61 (m, 4H),
7.38−7.33 (m, 4H), 7.33−7.20 (m, 6H), 3.71−3.58 (m, 2H), 3.34−
3.22 (m, 2H), 2.61 (s, 3H), 1.80−1.70 (m, 4H), 1.42−1.32 (m, 2H).
13C NMR (101 MHz, CDCl3): δ 181.5, 173.6, 155.3, 134.9, 133.2,
Compound 3h was too unstable to be characterized properly. It
decomposed upon an attempt to purify it; hence, the crude reaction
mixture was subjected to thermal rearrangement (vide infra) and the
corresponding triazaborine 4h was then purified and identified.
The following compounds were prepared according to the
aforementioned procedure.
4-(4-Diethylaminophenyldiazenyl)-3-methyl-1,1-diphenyl-
6,7,8,9-tetrahydro-5H-[1,3,2 λ4]oxazaborino[3,4-a]azepine (3a).
Yield: 26%. Mp: 193−195 °C. 1H NMR (400 MHz, CDCl3): δ
7.61−7.52 (m, 2H), 7.40−7.34 (m, 4H), 7.29−7.17 (m, 6H), 6.70−
6.60 (m, 2H), 3.63−3.53 (m, 2H), 3.45−3.31 (m, 4H), 3.22−3.16 (m,
2H), 2.48 (s, 3H), 1.80−1.65 (m, 4H), 1.40−1.30 (m, 2H), 1.23−1.12
(m, 6H). 13C NMR (101 MHz, CDCl3): δ 175.8, 173.3, 148.8, 143.4,
134.8, 133.3, 131.8, 127.2, 126.4, 123.6, 111.2, 51.1, 44.7, 29.8, 29.8,
26.3, 23.7, 22.3, 12.8. Anal. Calcd for C31H37BN4O (492.46): C, 75.61;
H, 7.57; N, 11.38. Found: C, 75.42; H, 7.51; N 11.20.
131.9, 128.1, 127.4, 126.9, 122.2, 119.0, 111.6, 51.5, 30.0, 29.6, 26.0,
23.5, 23.3. Anal. Calcd for C28H27BN4O (446.35): C, 75.34; H, 6.10;
N, 12.55. Found: C, 75.27; H, 6.18; N, 12.29.
3-Methyl-4-(4-nitrophenyldiazenyl)-1,1-diphenyl-6,7,8,9-tetrahy-
dro-5H-[1,3,2 λ4]oxazaborino[3,4-a]azepine (3h). Yield: 61%. 1H
NMR (400 MHz, CDCl3): δ 8.29−8.27 (m, 2H), 7.71−7.69 (m, 2H),
7.39−7.33 (m, 4H), 7.33−7.22 (m, 6H), 3.70−3.61 (m, 2H), 3.36−
3.26 (m, 2H), 2.63 (s, 3H), 1.80−1.74 (m, 4H), 1.40−1.35 (m, 2H).
HRMS (MALDI): calcd for C27H27BN4O3 [M + H]+ 467.22490 Da;
found [M + H]+ 467.22547 Da.
General Procedure for the Preparation of Triazaborines 4.24
Oxazaborines 3 (2 mmol) were heated at reflux in DMF (10 mL) for
the appropriate time (shown for the particular compound). The
reaction was monitored by TLC. The solvent was evaporated in vacuo,
and the crude reaction mixture was chromatographed on silica gel with
dichloromethane as the mobile phase to give the corresponding
triazaborines. The following compounds were prepared using the
aforementioned procedure.
4-Acetyl-2-(4-diethylaminophenyl)-1,1-diphenyl-2,5,6,7,8,9-hexa-
hydro-1H-[1,2,4,3 λ4]-triazaborino[4,5-d]azepine (4a). Yield: 1% (10
h). Mp: 194−196 °C. 1H NMR (400 MHz, CDCl3): δ 7.43−7.38 (m,
4H), 7.25−7.17 (m, 6H), 7.14−7.09 (m, 2H), 6.38−6.28 (m, 2H),
3.53−3.46 (m, 2H), 3.28−3.20 (m, 6H), 2.52 (s, 3H), 1.65−1.55 (m,
4H), 1.28−1.23 (m, 2H), 1.13−1.02 (m, 6H). 13C NMR (101 MHz,
CDCl3): δ 196.4, 164.3, 146.3, 137.6, 134.1, 134.1, 133.1, 127.5, 126.5,
124.5, 110.3, 51.5, 44.4, 29.5, 29.5, 27.5, 27.0, 23.1, 12.7. HRMS
(MALDI): calcd for C31H37BN4O [M]+ 492.30549 Da, [M + Na]+
515.29526 Da; found [M]+ 492.30507 Da, [M + Na]+ 515.29486 Da.
4-Acetyl-2-(4-methoxyphenyl)-1,1-diphenyl-2,5,6,7,8,9-hexahy-
dro-1H-[1,2,4,3 λ4]-triazaborino[4,5-d]azepine (4b). Yield: 6% (20
h). Mp: 143−145 °C. 1H NMR (400 MHz, CDCl3): δ 7.42−7.38 (m,
4H), 7.26−7.16 (m, 8H), 6.59−6.52 (m, 2H), 3.66 (s, 3H), 3.56−3.50
(m, 2H), 3.25−3.19 (m, 2H), 2.52 (s, 3H), 1.66−1.59 (m, 4H), 1.31−
1.22 (m, 2H). 13C NMR (101 MHz, CDCl3): δ 196.3, 164.8, 157.9,
145.5, 141.8, 134.0, 133.8, 127.6, 126.7, 124.4, 113.0, 55.4, 51.8, 29.8,
29.4, 27.4, 26.9, 22.8. Anal. Calcd for C28H30BN3O2 (451.37): C,
74.51; H, 6.70; N, 9.31. Found: C, 74.30; H, 6.69; N, 9.10.
4-(4-Methoxyphenyldiazenyl)-3-methyl-1,1-diphenyl-6,7,8,9-tet-
rahydro-5H-[1,3,2 λ4]oxazaborino[3,4-a]azepine (3b). Yield: 42%.
1
Mp: 160−162 °C. H NMR (400 MHz, CDCl3): δ 7.65−7.57 (m,
2H), 7.40−7.35 (m, 4H), 7.30−7.20 (m, 6H), 6.96−6.89 (m, 2H),
3.83 (s, 3H), 3.64−3.57 (m, 2H), 3.28−3.18 (m, 2H), 2.53 (s, 3H),
1.80−1.70 (m, 4H), 1.41−1.32 (m, 2H). 13C NMR (101 MHz,
CDCl3) δ 177.8, 173.4, 160.6, 147.5, 147.3, 133.3, 131.6, 127.2, 126.6,
123.2, 114.2, 55.6, 51.2, 29.8, 29.8, 26.2, 23.6, 22.7. Anal. Calcd for
C28H30BN3O2 (451.37): C, 74.51; H, 6.70; N, 9.31. Found: C, 74.79;
H, 6.76; N, 9.02.
3-Methyl-4-(4-methylphenyldiazenyl)-1,1-diphenyl-6,7,8,9-tetra-
hydro-5H-[1,3,2 λ4]oxazaborino[3,4-a]azepine (3c). Yield: 29%. Mp:
1
135−137 °C. H NMR (400 MHz, CDCl3): δ 7.56−7.51 (m, 2H),
7.39−7.33 (m, 4H), 7.30−7.17 (m, 8H), 3.64−3.54 (m, 2H), 3.26−
3.20 (m, 2H), 2.55 (s, 3H), 2.37 (s, 3H), 1.78−1.68 (m, 4H), 1.40−
1.30 (m, 2H). 13C NMR (101 MHz, CDCl3) δ 178.4, 173.5, 151.1,
139.4, 134.8, 133.3, 131.6, 129.7, 127.3, 126.6, 121.7, 51.2, 29.9, 29.8,
26.2, 23.5, 22.8, 21.5. Anal. Calcd for C28H30BN3O (435.37): C, 77.24;
H, 6.95; N, 9.65. Found: C, 77.49; H, 7.03; N, 9.51.
3-Methyl-4-(phenyldiazenyl)-1,1-diphenyl-6,7,8,9-tetrahydro-5H-
[1,3,2 λ4]oxazaborino[3,4-a]azepine (3d). Yield: 57%. Mp: 137−139
1
°C. H NMR (400 MHz, CDCl3): δ 7.66−7.61 (m, 2H), 7.42−7.35
4-Acetyl-2-(4-methylphenyl)-1,1-diphenyl-2,5,6,7,8,9-hexahydro-
1H-[1,2,4,3 λ4]-triazaborino[4,5-d]azepine (4c). Yield: 18% (9 h).
(m, 7H), 7.30−7.21 (m, 6H), 3.70−3.54 (m, 2H), 3.32−3.23 (m, 2H),
2.57 (s, 3H), 1.78−1.70 (m, 4H), 1.42−1.32 (m, 2H). 13C NMR (101
MHz, CDCl3) δ 179.0, 173.5, 153.1, 134.9, 133.3, 131.7, 129.0, 127.3,
127.1, 126.7, 121.8, 51.3, 29.9, 29.8, 26.1, 23.5, 22.9. HRMS
(MALDI): calcd for C27H28BN3O [M + H]+ 422.23982 Da, [M +
Na]+ 444.22177 Da; found [M + H]+ 422.24027 Da, [M + Na]+
444.22214 Da.
1
Mp: 141−143 °C. H NMR (400 MHz, CDCl3): δ 7.43−7.38 (m,
4H), 7.25−7.17 (m, 6H), 7.14−7.10 (m, 2H), 6.87−6.82 (m, 2H),
3.58−3.50 (m, 2H), 3.24−3.19 (m, 2H), 2.52 (s, 3H), 2.19 (s, 3H),
1.65−1.58 (m, 4H), 1.31−1.24 (m, 2H). 13C NMR (101 MHz,
CDCl3): δ 196.4, 165.0, 145.8, 145.5, 136.0, 134.1, 128.4, 127.6, 126.7,
123.0, 51.9, 29.8, 29.5, 27.4, 26.9, 22.7, 21.0. Anal. Calcd for
C28H30BN3O (435.37): C, 77.24; H, 6.95; N, 9.65. Found: C, 77.41;
H, 7.02; N, 9.39.
4-(4-Bromophenyldiazenyl)-3-methyl-1,1-diphenyl-6,7,8,9-tetra-
hydro-5H-[1,3,2 λ4]oxazaborino[3,4-a]azepine (3e). Yield: 48%. Mp:
1
163−165 °C. H NMR (400 MHz, CDCl3): δ 7.55−7.47 (m, 4H),
4-Acetyl-2-phenyl-1,1-diphenyl-2,5,6,7,8,9-hexahydro-1H-[1,2,4,3
λ4]-triazaborino[4,5-d]azepine (4d). Yield: 7% (6 h). Mp: 159−161
7.38−7.34 (m, 4H), 7.30−7.20 (m, 6H), 3.68−3.52 (m, 2H), 3.30−
3.19 (m, 2H), 2.56 (s, 3H), 1.80−1.65 (m, 4H), 1.40−1.33 (m, 2H).
13C NMR (101 MHz, CDCl3): δ 179.6, 173.5, 151.9, 133.2, 132.2,
131.6, 128.1, 127.3, 126.7, 123.2, 122.9, 51.3, 29.9, 29.7, 26.1, 23.5,
1
°C. H NMR (400 MHz, CDCl3): δ 7.44−7.39 (m, 4H), 7.25−7.21
(m, 6H), 7.20−7.17 (m, 2H), 7.08−6.99 (m, 3H), 3.60−3.49 (m, 2H),
3.24−3.19 (m, 2H), 2.54 (s, 3H), 1.65−1.59 (m, 4H), 1.32−1.23 (m,
G
dx.doi.org/10.1021/om500219g | Organometallics XXXX, XXX, XXX−XXX